Beta Bionics, Inc. (BBNX) Return on Sales (2024 - 2026)

Beta Bionics (BBNX) has 3 years of Return on Sales data on file, last reported at 0.01% in Q1 2026.

• Quarterly Return on Sales changed 0.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (changed 0.0% YoY) and the FY2025 annual result came in at 0.01%, changed 0.0% from the prior year.
• Return on Sales retreated to 0.01% in Q1 2026 per BBNX's latest filing, from 0.0% in the prior quarter.
• The five-year high for Return on Sales was 0.0% in Q4 2025, with the low at 0.01% in Q1 2025.
• Average Return on Sales over 3 years is 0.01%, with a median of 0.01% recorded in 2024.
• The widest YoY moves for Return on Sales: up 0 bps in 2025, down 0 bps in 2025.
• Beta Bionics' Return on Sales stood at 0.01% in 2024, then climbed by 29 bps to 0.0% in 2025, then sank by 89 bps to 0.01% in 2026.
• Business Quant data shows BBNX's Return on Sales at 0.01% in Q1 2026, 0.0% in Q4 2025, and 0.01% in Q3 2025.